Raymond James Financial
IBB icon

Raymond James Financial’s iShares Biotechnology ETF IBB Stock Holding History

Raymond James Financial’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$200M Buy
1,050,594
+20,885
+2% +$3.59M 0.05% 311
2026
Q1 		$174M Buy
1,029,709
+35,398
+4% +$6.05M 0.05% 321
2025
Q4 		$168M Buy
994,311
+736,881
+286% +$120M 0.05% 321
2025
Q3 		$37.2M Sell
257,430
-2,311
-0.9% -$315K 0.01% 992
2025
Q2 		$32.9M Sell
259,741
-91,459
-26% -$11.2M 0.01% 1030
2025
Q1 		$44.9M Sell
351,200
-64,881
-16% -$8.8M 0.02% 777
2024
Q4 		$55M Buy
+416,081
New +$58.5M 0.02% 673

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Raymond James Financial's IBB Position: Q2 2026 in Review

Raymond James Financial increased its iShares Biotechnology ETF (IBB) stake by 2% in Q2 2026, buying an estimated $3.59M and bringing the position to 1,050,594 shares worth $200M. The position accounts for 0.05% of the portfolio, ranked #311.

Raymond James Financial first reported a position in IBB in Q4 2024 and has held it in 7 quarters since. 955 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Raymond James Financial held 1,050,594 shares of iShares Biotechnology ETF worth $200M as of Q2 2026.
  • Raymond James Financial bought 20,885 iShares Biotechnology ETF shares in Q2 2026, an estimated $3.59M.
  • iShares Biotechnology ETF made up 0.05% of Raymond James Financial's portfolio in Q2 2026, its #311 holding.
  • Raymond James Financial first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 7 quarters since.
  • 955 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.